首页> 外文会议>International Conference on Information Science and Technology Applications >Retrospective analysis of Pulmonary Surfactant on Respiratory Distress Syndrome of Late Premature or Full-term Infants Paper Title
【24h】

Retrospective analysis of Pulmonary Surfactant on Respiratory Distress Syndrome of Late Premature or Full-term Infants Paper Title

机译:肺表面活性剂对晚期过早或全职婴幼儿纸标题呼吸窘迫综合征的回顾性分析

获取原文

摘要

This retrospective analysis evaluates the effcacy of pulmonary surfactant in respiratory distress syndrome treatment of late premature or trem infants. We compared infants receiving Curosurf pig pulmonary surfactant (PS group n=89) with those infants who didn't (control group n=77). Both were treated with routine treatment and mechanical ventilation. The highest oxygenation indexes in PS group were obviously higher than those in control group (P<0.001), The time of hospital stay, Mechanical ventilation and CPAP, the incidence of Ventilator-associated pneumonia and hospitalization expenses of PS group were obviously higher than that in control group (P<0.05). There were no significant differences about NO inhalation, the incidence of pulmonar >0.05). PS should be applied for late premature and full-term RDS patients in the early stage, and clinical studies on PS treatment of late premature infants or full-term infants for the best medication time and optimal dosage should be further explored.
机译:该回顾性分析评估了肺表面活性剂在呼吸窘迫综合征治疗后期过早或TREM婴儿的效率。我们将婴儿与没有(对照组N = 77)的那些婴儿进行接受的婴儿接受Curosurf猪肺表面活性剂(PS组N = 89)。两者都用常规处理和机械通气治疗。 PS组中最高氧合指数明显高于对照组(P <0.001),住院时间,机械通风和CPAP,呼吸机相关肺炎的发病率和PS组的住院费用明显高于此在对照组(P <0.05)。没有吸入没有显着差异,润摩尔的发生率> 0.05)。 PS应在早期的早期和全术期RDS患者中申请,并进一步探索对后期早产儿或最佳药物的全婴儿的临床研究应进一步探索。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号